Bayer | BAYN - Operating Expenses

Stock Price
42.34
Daily Change
-0.46 -1.07%
Monthly
-8.68%
Yearly
87.01%
Q1 Forecast
42.20

Bayer reported EUR10.2B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Air Liquide EUR 10.37B 6.15B Dec/2025
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.28B 67M Sep/2025
Amarin USD 51.37M 14.6M Sep/2025
Arkema EUR 2.08B 151M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 13.84B 1.11B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Beiersdorf EUR 4.37B 143M Jun/2025
Corteva USD 3.1B 217M Dec/2025
Covestro EUR -2.22B 5.55B Sep/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Genmab DKK 565M 38M Jun/2025
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Henkel EUR 8.79B 444M Jun/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Johnson Matthey GBP 5.21B 600M Dec/2025
Linde USD 6.21B 52M Sep/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Nutrien USD 4.64B 579M Dec/2025
Philips EUR 4.38B 405M Dec/2025
PPG Industries USD 3.46B 4.34B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
SAP EUR 6.91B 1.34B Dec/2025
Solvay EUR 1.06B 28M Sep/2025
UCB EUR 2.36B 108M Dec/2024
Umicore EUR 8.39B 4.03B Jun/2025
Vinci EUR 34.12B 2.72B Dec/2025